Orthopaedic manifestations of neurofibromatosis type 1: A case report
Florentina Năstase,Diana Sabina Radaschin,Elena Niculeț,Andrei Vlad Brădeanu,Mădălina Codruța Verenca,Aurel Nechita,Valentin Chioncel,Lawrence Chukwudi Nwabudike,Liliana Baroiu,Eduard Drima Polea,Silvia Fotea,Lucretia Anghel,Alexandru Nechifor,Alin Laurenţiu Tatu,Diana Radaschin,Andrei Brădeanu,Mădălina Verenca,Lawrence Nwabudike,Eduard Polea,Alin Tatu
DOI: https://doi.org/10.3892/etm.2021.11058
IF: 2.7
2021-12-13
Experimental and Therapeutic Medicine
Abstract:Neurofibromatosis type 1 (NF1) or von Recklinghausen disease is one of the most common autosomal dominant genetic diseases. It is characterized by 'café-au-lait' spots and multiple tumors starting from the central and peripheric nervous system. The diagnosis is determined on two out of seven criteria: i) A total of 6 or more light brown spots larger than 5 mm in diameter (pre-puberty) or 15 mm in diameter (post-puberty); ii) a total of 2 or more neurofibromas or one plexiform neurofibroma; iii) axillary or inguinal freckling; iv) optic glioma; v) a total of 2 or more Lisch nodules; vi) bone abnormalities: tibia pseudarthrosis or dysplasia of the sphenoid wing; and vii) a relative of first degree having an NF1 diagnosis. A total of ~50% of patients have significant musculoskeletal manifestation, with scoliosis and congenital pseudarthrosis of tibia most common. Management of the orthopaedic manifestations of NF1 is often difficult. Due to NF1 influencing multiple organ systems, patients are likely to benefit most from a multidisciplinary treatment strategy.
medicine, research & experimental